Advertisement
DHR vs NVNO
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHR is a Hold and NVNO is a Hold.
DHR in downward trend: price may drop because broke its higher Bollinger Band on October 15, 2026
DHR broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 42 similar instances where the stock broke above the upper band. In 27 of the 42 cases the stock fell afterwards. This puts the odds of success at 64%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for DHR moved out of overbought territory on September 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In 13 of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at 45%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on DHR as a result. In 57 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.
The Moving Average Convergence Divergence (MACD) for DHR just turned positive on October 14, 2026. Looking at past instances where DHR's MACD turned positive, the stock continued to rise in 25 of 47 cases over the following month. The odds of a continued upward trend are 53%.
Following a +3.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where DHR advanced for three days, in 174 of 319 cases, the price rose further within the following month. The odds of a continued upward trend are 55%.
The Aroon Indicator entered an Uptrend today. In 111 of 199 cases where DHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 56%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 14 (best 1 - 100 worst), indicating outstanding price growth. DHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.127) is normal, around the industry mean (66.046). P/E Ratio (41.465) is within average values for comparable stocks, (2.422). Projected Growth (PEG Ratio) (1.361) is also within normal values, averaging (3.473). Dividend Yield (0.007) settles around the average of (0.002) among similar stocks. P/S Ratio (5.900) is also within normal values, averaging (9.775).
The Tickeron PE Growth Rating for this company is 53 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 77 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
NVNO's Indicator enters downward trend
The Aroon Indicator for NVNO entered a downward trend on September 25, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 253 similar instances where the Aroon Indicator formed such a pattern. In 223 of the 253 cases the stock moved lower. This puts the odds of a downward move at 88%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day moving average for NVNO crossed bearishly below the 50-day moving average on September 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVNO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where NVNO's RSI Indicator exited the oversold zone, 24 of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 62%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for NVNO just turned positive on October 19, 2026. Looking at past instances where NVNO's MACD turned positive, the stock continued to rise in 30 of 45 cases over the following month. The odds of a continued upward trend are 67%.
Following a +4.25% 3-day Advance, the price is estimated to grow further. Considering data from situations where NVNO advanced for three days, in 191 of 252 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
NVNO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 41 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.246) is normal, around the industry mean (2.923). P/E Ratio (-0.294) is within average values for comparable stocks, (2.388). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. NVNO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVNO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
DHR | NVNO | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 30 | 68 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 18 Undervalued | 41 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 77 | 98 | |
PRICE GROWTH RATING 1..100 | 14 | 84 | |
P/E GROWTH RATING 1..100 | 53 | 16 | |
SEASONALITY SCORE 1..100 | 50 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
DHR's Valuation (18) in the Medical Specialties industry is in the same range as NVNO (41) in the null industry. This means that DHR’s stock grew similarly to NVNO’s over the last 12 months.
DHR's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as NVNO (100) in the null industry. This means that DHR’s stock grew similarly to NVNO’s over the last 12 months.
DHR's SMR Rating (77) in the Medical Specialties industry is in the same range as NVNO (98) in the null industry. This means that DHR’s stock grew similarly to NVNO’s over the last 12 months.
DHR's Price Growth Rating (14) in the Medical Specialties industry is significantly better than the same rating for NVNO (84) in the null industry. This means that DHR’s stock grew significantly faster than NVNO’s over the last 12 months.
NVNO's P/E Growth Rating (16) in the null industry is somewhat better than the same rating for DHR (53) in the Medical Specialties industry. This means that NVNO’s stock grew somewhat faster than DHR’s over the last 12 months.
| DHR | NVNO | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 45% | 2 days ago 62% |
| Stochastic ODDS (%) | 1 day ago 60% | 2 days ago 83% |
| Momentum ODDS (%) | 1 day ago 64% | N/A |
| MACD ODDS (%) | 1 day ago 53% | 2 days ago 67% |
| TrendWeek ODDS (%) | 1 day ago 62% | 2 days ago 85% |
| TrendMonth ODDS (%) | 1 day ago 57% | 2 days ago 83% |
| Advances ODDS (%) | 8 days ago 55% | 16 days ago 76% |
| Declines ODDS (%) | 3 days ago 59% | 2 days ago 85% |
| BollingerBands ODDS (%) | 1 day ago 64% | 2 days ago 71% |
| Aroon ODDS (%) | 1 day ago 56% | 2 days ago 88% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DHR’s FA Score shows that 2 FA rating(s) are green while NVNO’s FA Score has 1 green FA rating(s).
- DHR’s FA Score: 2 green, 3 red.
- NVNO’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DHR’s TA Score shows that 4 TA indicator(s) are bullish while NVNO’s TA Score has 5 bullish TA indicator(s).
- DHR’s TA Score: 4 bullish, 4 bearish.
- NVNO’s TA Score: 5 bullish, 3 bearish.
Price Growth
DHR (@Medical Specialties) experienced а +4.08% price change this week, while NVNO (@Medical/Nursing Services) price change was -0.95% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -3.15%. For the same industry, the average monthly price growth was -6.50%, and the average quarterly price growth was +42.74%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.
Reported Earning Dates
DHR is expected to report earnings on Feb 03, 2027.
NVNO is expected to report earnings on Oct 30, 2026.
Industries' Descriptions
@Medical Specialties (-3.15% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (-1.62% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
DHR and
Correlation & Price change
A.I.dvisor indicates that over the last year, DHR has been closely correlated with TMO. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if DHR jumps, then TMO could also see price increases.
| Ticker / NAME | Correlation To DHR | 1D Price Change % | ||
|---|---|---|---|---|
| DHR | 100% | -1.76% | ||
| TMO - DHR | 73% Closely correlated | -2.52% | ||
| RGEN - DHR | 68% Closely correlated | -0.72% | ||
| BIO - DHR | 64% Loosely correlated | +0.83% | ||
| A - DHR | 60% Loosely correlated | -2.17% | ||
| BRKR - DHR | 58% Loosely correlated | -3.04% | ||
More | ||||
NVNO and
Correlation & Price change
A.I.dvisor tells us that NVNO and HBIO have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVNO and HBIO's prices will move in lockstep.
| Ticker / NAME | Correlation To NVNO | 1D Price Change % | ||
|---|---|---|---|---|
| NVNO | 100% | -4.31% | ||
| HBIO - NVNO | 31% Poorly correlated | +1.80% | ||
| DHR - NVNO | 31% Poorly correlated | +4.29% | ||
| RGEN - NVNO | 30% Poorly correlated | +0.63% | ||
| TWST - NVNO | 30% Poorly correlated | +4.51% | ||
| RDNT - NVNO | 28% Poorly correlated | -1.78% | ||
More | ||||